Duvakitug demonstrated a significant endoscopic response in 48% of patients with Crohn's disease, with the 900 mg dose exceeding placebo response rates in a phase 2b trial.
- 7 cites
The lancet. Gastroenterology & hepatology
Elsevier BV · Clinical Medicine · ISSN 2468-1253
- Impact (2-yr)
- 13.0
- h-index
- 174
- Open access
- 32%
- Works
- 2.5K
- Papers this month
- 24
Rebuilt
Moved this week
Duvakitug significantly improved clinical remission rates in patients with moderate to severe ulcerative colitis, with response rates of up to 48% at week 14.
- 7 cites
Latest in The lancet Gastroenterology & hepatology
Newest first · last 60 days
Bowel endometriosis affects 8-12% of women with endometriosis, mainly in the rectosigmoid colon, and often coexists with other pelvic lesions.
Restoring gut barrier function with targeted therapies could transform treatment of gut-brain interaction disorders, reducing symptoms in conditions like IBS and dyspepsia.
DD01 significantly reduces liver fat by at least 30% in 76% of adults with MASH or MASLD after 12 weeks, outperforming placebo in a phase 2 trial.
A blood-based assay detects colorectal cancer and advanced adenomas with 95% accuracy, showing 91% sensitivity for cancers and 81% for advanced adenomas in a multicentre study.
- 1 cites
AI-assisted colonoscopy in Lynch syndrome surveillance did not significantly increase adenoma detection rates, with a 33.8% rate compared to 30.9% in standard procedures.
- Open access
- 1 cites
Short-course Toronto HCV protocol achieved undetectable HCV RNA in 98% of non-liver solid organ transplant recipients from HCV-positive donors, with no impact on 2-year survival.
Non-opioid treatments, especially neuromodulators like gabapentinoids, show promise for managing chronic pancreatitis pain affecting 80-90% of patients.
Aspirin does not improve disease-free survival and reduces overall survival in patients after curative treatment of colorectal cancer liver metastases, with increased serious adverse events.
Liver fibrosis and steatotic liver disease affect over 4% and 43% of community-dwelling adults in China, with higher prevalence linked to metabolic and alcohol factors.
Genetic variant rs2099161 at the SUSD1 locus is significantly associated with renal impairment in decompensated cirrhosis, with a combined p-value of 8.31×10^-11.
Early top-down anti-TNF therapy from Crohn's disease diagnosis reduces surgery and disease progression over 5 years, with a hazard ratio of 5.23 for surgery.
Multigene germline panel testing reveals pathogenic variants in 15.2% of unselected colorectal cancer patients, with significant implications beyond early-onset cases.
Follow The lancet Gastroenterology & hepatology in the app
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4